At the Nova Scotia Health Authority, all research projects involving patients, staff, resources or data are reviewed and approved by our Research Ethics Board (REB) before the research begins.
This requirement also applies to research involving human participants, human biological materials as well as human embryos, fetuses, fetal tissue, reproductive materials and stem cells. This applies to materials derived from living and deceased individuals.
The REB ensures that all research projects meet the requirements of the Tri-Council Policy Statement, ICH-GCP Guidelines and Health Canada Division 5 Food and Drug regulations all of which protect the safety and well being of research participants.
If you are a patient involved in a Research study or clinical trial and have ethical concerns, please contact the Research Ethics Board office: Ken Jenkins, Manager, 902-473-8426 email@example.com